Understanding CD8(+) T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope

The Wilms' tumor 1 (WT1) antigen is expressed in solid and hematological malignancies, but not healthy tissues, making it a promising target for cancer immunotherapies. Immunodominant WT1 epitopes, the native HLA-A2/WT1(126-134) (RMFPNAPYL) (HLA-A2/RMFPNAPYL epitope (WT1A)) and its modified var...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thi HO, Tan, Amabel CL, Xiang, Sue D, Goubier, Anne, Harland, Kim L, Clemens, E Bridie, Plebanski, Magdalena, Kedzierska, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382434/
https://www.ncbi.nlm.nih.gov/pubmed/28435676
http://dx.doi.org/10.1038/cti.2017.4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382434/
https://www.ncbi.nlm.nih.gov/pubmed/28435676
http://dx.doi.org/10.1038/cti.2017.4

Ejemplares similares